Tsimberidou et al developed a simple prognostic score for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This can help identify patients who may benefit from a more aggressive or novel therapy. The authors are from the University of Texas M.D. Anderson Cancer Center.